Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Pain 4Neoplasms 3Chronic Pain 1Cancer Pain 1Agnosia 1

Interventions

Ketamine 3Sodium Chloride 2Ropivacaine 2Propofol 2Analgesics, Opioid 2Analgesia, Patient-Controlled 2parecoxib 1Tea 1Tapentadol 1Surveys and Questionnaires 1Sevoflurane 1Saline Solution 1Lidocaine 1Ketorolac 1Ibuprofen 1Epinephrine 1Dexamethasone 1Codeine 1Clonidine 1Circumcision, Male 1Celecoxib 1Anesthesia, General 1Acupuncture Therapy 1Acetaminophen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Agnosia × Tapentadol × Clear all
NCT01264887 2019-11-04

Tapentadol in Chronic Malignant Tumour Related Pain

Grünenthal GmbH

Phase 3 Terminated
31 enrolled 19 charts

Agnosia, Neoplasms, Pain, Chronic Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡